Similarly, IL-8 levels were significantly higher in PCa patients than in controls, suggesting that IL-8 may be a biomarker for PCa etiology and may also be an indicator for tumor progression [90]. This evidence concerns the gene CXCL8 and posterior cortical atrophy.